Cargando…
Obstacles and Coping Strategies of CAR-T Cell Immunotherapy in Solid Tumors
Chimeric antigen receptor (CAR) T-cell immunotherapy refers to an adoptive immunotherapy that has rapidly developed in recent years. It is a novel type of treatment that enables T cells to express specific CARs on their surface, then returns these T cells to tumor patients to kill the corresponding...
Autores principales: | Miao, Lele, Zhang, Zhengchao, Ren, Zhijian, Tang, Futian, Li, Yumin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170155/ https://www.ncbi.nlm.nih.gov/pubmed/34093592 http://dx.doi.org/10.3389/fimmu.2021.687822 |
Ejemplares similares
-
Gene-Edited Interleukin CAR-T Cells Therapy in the Treatment of Malignancies: Present and Future
por: Zhang, Zhengchao, et al.
Publicado: (2021) -
Reactions Related to CAR-T Cell Therapy
por: Miao, Lele, et al.
Publicado: (2021) -
A Bibliometric and Knowledge-Map Analysis of CAR-T Cells From 2009 to 2021
por: Miao, Lele, et al.
Publicado: (2022) -
Application of Immunotherapy in Hepatocellular Carcinoma
por: Miao, Lele, et al.
Publicado: (2021) -
Special Chimeric Antigen Receptor (CAR) Modifications of T Cells: A Review
por: Miao, Lele, et al.
Publicado: (2022)